In this episode of the ATiO Podcast, we are honored to welcome Prof. David Hunter, a world-renowned leader in osteoarthritis research. As the Florance and Cope Chair of Rheumatology at the University of Sydney and Editor-in-Chief of Osteoarthritis and Cartilage, Professor Hunter has been instrumental in shaping our modern understanding of osteoarthritis.

Our conversation explores the complexity of OA—from disease mechanisms and current treatment strategies to the scientific and clinical challenges that have slowed therapeutic innovation. Professor Hunter shares insights into why osteoarthritis should be understood as a heterogeneous group of conditions, rather than a single disease entity.

We also discuss the role of prevention, lifestyle factors, emerging technologies, and international collaboration in advancing OA care. This episode offers a concise yet compelling look at how rigorous science and global cooperation are redefining the future of osteoarthritis management.

In this episode of the ATiO Podcast, we have the honor to welcome Prof. Ivan Martin, a world-renowned expert in tissue engineering and translational research. As Chair of the Department of Biomedicine at the University of Basel, Prof. Martin has spent over two decades advancing innovative solutions for musculoskeletal repair.

Our conversation dives into the intersection of basic science, clinical application, and entrepreneurship, highlighting the journey from lab bench to operating room. Prof. Martin shares key insights from his visionary work in cartilage regeneration, as well as the challenges of bridging academia and industry.

We also discuss the broader impact of regenerative therapies on healthcare systems, the importance of interdisciplinary collaboration, and the future of patient-specific treatment strategies. This episode offers a compelling look at how visionary research is transforming the landscape of orthopaedic care.

In this episode of the ATiO Podcast, we delve into the pioneering work of ZuriMED Technologies, a Swiss-based company specializing in advanced medical technologies for soft tissue repair. Founded in 2015 as a spin-off from the University of Zurich and ETH Zurich, ZuriMED has rapidly emerged at the forefront of orthopaedic innovation.

We are joined by Ronja Senn, Head of Sales at ZuriMED, who shares insights into the company’s mission to develop breakthrough technologies that enhance surgical outcomes and improve patient recovery. Under the leadership of Xiang Li, ZuriMED has introduced the Surgical-Fiberlock™ technology, a minimally invasive solution designed to revolutionize soft tissue repair.

In 2024, ZuriMED’s innovative approach earned them the prestigious ATiO Early-Stage Pitch Contest award, recognizing their significant contributions to the field. Ronja discusses the journey leading to this achievement, the challenges they’ve faced, and ZuriMED’s exciting plans for the future.

In this episode of the ATiO Podcast, we delve into the professional journey of Emil Billbäck, Board Member of the ATiO Foundation and CEO of Bonesupport.

With a rich history in the life sciences industry, Emil shares his experiences from previous leadership roles at BSN Medical and Essity, and discusses what inspired him to join Bonesupport in 2018.

He elucidates Bonesupport’s core vision and mission, highlighting the company’s contributions to the field of orthobiologics. We explore the CERAMENT™ technology, which forms the backbone of Bonesupport’s product offerings and its significant impact on both surgeons and patients.

Emil also sheds light on the company’s major milestones and listeners will gain insights into the upcoming innovations in orthopaedics that excite Emil, as well as the challenges and successes he has encountered during his tenure.

Join host Noorjan Saidi for an engaging conversation with Emil Billbäck, and discover how BONESUPPORT is planning to revolutionize muskuloskeletal care!

Note: This episode was recorded before Emil Billbäck joined the board of the ATiO Foundation.

In the first episode of the ATiO Podcast, we explore the journey of the Advanced Therapies in Orthopaedics Foundation (ATiO).

We trace its origins, discuss its present contributions, and look towards its future ambitions with our special guests and founders, Michiel Bröcker and Prof. Dr. Tobias Winkler.

• Michiel Bröcker, a pioneer in healthcare investment and the Managing Director at UBS Healthcare Investments, shares his expertise in business and leadership. His role in fostering medical collaborations has been pivotal in advancing innovative healthcare solutions.

• Prof. Dr. Tobias Winkler, a renowned orthopaedics expert, brings his extensive research and academic insights, offering a comprehensive view of the challenges and developments in orthopaedic therapies.

Together, they delve into the creation of the ATiO Alliance, highlighting its mission and the teamwork propelling its achievements. The episode covers ATiO's ongoing projects, its vital role in the orthopaedic community, and its future objectives.

Moreover, the discussion touches on the current landscape of orthopaedics, addressing the existing challenges and the prospective advancements in patient care.

Join host Noorjan Saidi to discover the impact of the ATiO Alliance in the field of orthopaedics!